A federal judge on Thursday dismissed a pair of patent infringement lawsuits by Teva Pharmaceutical Industries Ltd that sought to block Eli Lilly and Co from bringing its migraine drug Emgality to market in the United States.
from Reuters: Health News https://ift.tt/2Ojdng2
No comments:
Post a Comment